$PFHO
PACIFIC HEALTH CARE ORGANIZATION INC

2024 Q3 Form 10-Q Financial Statement

#000118518524000764 Filed on August 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $1.528M $1.570M
YoY Change 11.02% 20.87%
Cost Of Revenue $334.7K
YoY Change 25.17%
Gross Profit $1.235M
YoY Change 19.75%
Gross Profit Margin 78.68%
Selling, General & Admin $1.034M
YoY Change 17.91%
% of Gross Profit 83.72%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $8.384K $9.114K
YoY Change -6.18% -2.39%
% of Gross Profit 0.74%
Operating Expenses $1.376M $1.378M
YoY Change 11.97% 19.43%
Operating Profit $151.6K $192.0K
YoY Change 3.11% 32.3%
Interest Expense $107.0K
YoY Change 6.83%
% of Operating Profit 55.73%
Other Income/Expense, Net $8.783K $55.77K
YoY Change 94.14% 81.36%
Pretax Income $265.2K $299.0K
YoY Change 6.5% 21.9%
Income Tax $90.35K $83.44K
% Of Pretax Income 34.07% 27.91%
Net Earnings $174.9K $215.6K
YoY Change -2.38% 22.18%
Net Earnings / Revenue 11.45% 13.73%
Basic Earnings Per Share $0.01 $0.02
Diluted Earnings Per Share $0.01 $0.02
COMMON SHARES
Basic Shares Outstanding 12.80M shares 12.80M shares
Diluted Shares Outstanding 12.82M shares 12.82M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.70M
YoY Change 7.42%
Cash & Equivalents $2.546M $2.619M
Short-Term Investments $8.084M
Other Short-Term Assets $226.2K
YoY Change -6.09%
Inventory
Prepaid Expenses
Receivables $1.093M $941.3K
Other Receivables $0.00
Total Short-Term Assets $12.07M $11.87M
YoY Change 7.48% 7.23%
LONG-TERM ASSETS
Property, Plant & Equipment $57.93K $64.63K
YoY Change -21.59% -19.37%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $7.110K $7.110K
YoY Change 0.0% 0.0%
Total Long-Term Assets $65.04K $71.74K
YoY Change -19.69% -17.79%
TOTAL ASSETS
Total Short-Term Assets $12.07M $11.87M
Total Long-Term Assets $65.04K $71.74K
Total Assets $12.14M $11.94M
YoY Change 7.29% 7.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $175.0K $163.1K
YoY Change 43.49% 103.24%
Accrued Expenses $440.4K $424.3K
YoY Change 39.96% 23.26%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $747.5K $726.0K
YoY Change -3.73% -9.16%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $0.00
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $747.5K $726.0K
Total Long-Term Liabilities $0.00
Total Liabilities $747.5K $726.0K
YoY Change -5.64% -10.91%
SHAREHOLDERS EQUITY
Retained Earnings $10.96M $10.79M
YoY Change 8.61% 8.81%
Common Stock $12.80K $12.80K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $11.39M $11.22M
YoY Change
Total Liabilities & Shareholders Equity $12.14M $11.94M
YoY Change 7.29% 7.03%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income $174.9K $215.6K
YoY Change -2.38% 22.18%
Depreciation, Depletion And Amortization $8.384K $9.114K
YoY Change -6.18% -2.39%
Cash From Operating Activities -$41.39K
YoY Change -113.43%
INVESTING ACTIVITIES
Capital Expenditures $2.030K
YoY Change 61.11%
Acquisitions
YoY Change
Other Investing Activities -$176.2K
YoY Change -115.94%
Cash From Investing Activities -$178.2K
YoY Change -116.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -41.39K
Cash From Investing Activities -178.2K
Cash From Financing Activities 0.000
Net Change In Cash -219.6K
YoY Change -172.87%
FREE CASH FLOW
Cash From Operating Activities -$41.39K
Capital Expenditures $2.030K
Free Cash Flow -$43.42K
YoY Change -114.15%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Address City Or Town
EntityAddressCityOrTown
Irvine
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei City Area Code
CityAreaCode
949
dei Local Phone Number
LocalPhoneNumber
721-8272
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12800000 shares
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2619437 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2565992 usd
CY2024Q2 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
8083936 usd
CY2023Q4 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
7877752 usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
12944 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
32814 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
941313 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1020580 usd
CY2024Q2 us-gaap Deferred Income Taxes And Other Assets Current
DeferredIncomeTaxesAndOtherAssetsCurrent
52061 usd
CY2023Q4 us-gaap Deferred Income Taxes And Other Assets Current
DeferredIncomeTaxesAndOtherAssetsCurrent
38871 usd
CY2024Q2 us-gaap Prepaid Taxes
PrepaidTaxes
27141 usd
CY2023Q4 us-gaap Prepaid Taxes
PrepaidTaxes
0 usd
CY2024Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
146968 usd
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
179702 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
11870856 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
11682897 usd
CY2024Q2 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
241167 usd
CY2023Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
255783 usd
CY2024Q2 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
13283 usd
CY2023Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
21620 usd
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
254450 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
277403 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
189818 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
200009 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
64632 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
77394 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
56489 usd
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7110 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7110 usd
CY2024Q2 us-gaap Assets
Assets
11942598 usd
CY2023Q4 us-gaap Assets
Assets
11823890 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
163133 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
159789 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
424318 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
367609 usd
CY2024Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0 usd
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
296452 usd
CY2024Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
94858 usd
CY2023Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
109013 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
44519 usd
CY2024Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
43711 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
30919 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
726020 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1008301 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11970 usd
CY2024Q2 us-gaap Liabilities
Liabilities
726020 usd
CY2023Q4 us-gaap Liabilities
Liabilities
1020271 usd
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
16000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
16000 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
16000 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
16000 shares
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
16 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
16 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12800000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12800000 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12800000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12800000 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
12800 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
12800 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
416057 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
416057 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
10787705 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
10374746 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
11216578 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
10803619 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11942598 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11823890 usd
CY2024Q2 us-gaap Revenues
Revenues
1569954 usd
CY2023Q2 us-gaap Revenues
Revenues
1324053 usd
us-gaap Revenues
Revenues
2996664 usd
us-gaap Revenues
Revenues
2665590 usd
CY2024Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9114 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9337 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
18541 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
18716 usd
CY2024Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-19906 usd
CY2023Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
934 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-19870 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1164 usd
CY2024Q2 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
56883 usd
CY2023Q2 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
60563 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
118280 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
116817 usd
CY2024Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
666564 usd
CY2023Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
633394 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
1346497 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
1303499 usd
CY2024Q2 us-gaap Professional Fees
ProfessionalFees
117695 usd
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
101101 usd
us-gaap Professional Fees
ProfessionalFees
203188 usd
us-gaap Professional Fees
ProfessionalFees
174203 usd
CY2024Q2 us-gaap General Insurance Expense
GeneralInsuranceExpense
78648 usd
CY2023Q2 us-gaap General Insurance Expense
GeneralInsuranceExpense
65115 usd
us-gaap General Insurance Expense
GeneralInsuranceExpense
158105 usd
us-gaap General Insurance Expense
GeneralInsuranceExpense
148596 usd
CY2024Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
200277 usd
CY2023Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
189820 usd
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
389485 usd
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
388592 usd
CY2024Q2 us-gaap Other Expenses
OtherExpenses
55771 usd
CY2023Q2 us-gaap Other Expenses
OtherExpenses
30752 usd
us-gaap Other Expenses
OtherExpenses
66502 usd
us-gaap Other Expenses
OtherExpenses
64754 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
212913 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
87919 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
348748 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
221675 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
1377959 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
1178935 usd
us-gaap Operating Expenses
OperatingExpenses
2629476 usd
us-gaap Operating Expenses
OperatingExpenses
2438016 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
191995 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
145118 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
367188 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
227574 usd
CY2024Q2 us-gaap Interest Income Other
InterestIncomeOther
107004 usd
CY2023Q2 us-gaap Interest Income Other
InterestIncomeOther
100158 usd
us-gaap Interest Income Other
InterestIncomeOther
206249 usd
us-gaap Interest Income Other
InterestIncomeOther
199974 usd
CY2024Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
107004 usd
CY2023Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
100158 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
206249 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
199974 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
298999 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
245276 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
573437 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
427548 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
83443 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
68849 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
160478 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
120012 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
215556 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
176427 usd
us-gaap Net Income Loss
NetIncomeLoss
412959 usd
us-gaap Net Income Loss
NetIncomeLoss
307536 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12800000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12800000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12800000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12800000 shares
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12816000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12816000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12816000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12816000 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
11317291 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
131109 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
11448400 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
176427 usd
CY2023Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1280000 usd
CY2023Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1600 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
10343227 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
10803619 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
197403 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
11001022 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
215556 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
11216578 usd
us-gaap Net Income Loss
NetIncomeLoss
412959 usd
us-gaap Net Income Loss
NetIncomeLoss
307536 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
18541 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
18716 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-19870 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1164 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
30000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
24405 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-99137 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-70406 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-32734 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-16523 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
13190 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
82000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
0 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
508 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3344 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-182754 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
56709 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
11708 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
12792 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
10167 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-323593 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
120225 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
249563 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
266778 usd
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
7877752 usd
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
8748435 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
8053936 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
7642981 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5779 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1473 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-181963 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1103981 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
14155 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
1110984 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-14155 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1110984 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
53445 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
259775 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2565992 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2036432 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2619437 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2296207 usd
us-gaap Interest Paid
InterestPaid
0 usd
us-gaap Interest Paid
InterestPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
498000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
82000 usd
us-gaap Dividends
Dividends
57858 usd
us-gaap Dividends
Dividends
170616 usd
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Reclassifications</i></b> – Certain reclassifications have been made to prior year amounts to conform to the current year presentations. These changes had no impact on the Company’s total assets or reported net income.</p>
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
12944 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
32814 usd
pfho Number Of Customers
NumberOfCustomers
3 pure
CY2023Q4 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P12M
us-gaap Operating Lease Expense
OperatingLeaseExpense
22803 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
20693 usd
CY2023Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.1
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12800000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12800000 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
16000 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
16000 shares
us-gaap Dividends Cash
DividendsCash
1281600 usd
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
16000 shares
us-gaap Net Income Loss
NetIncomeLoss
412959 usd
us-gaap Net Income Loss
NetIncomeLoss
307536 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12800000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12800000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
us-gaap Net Income Loss
NetIncomeLoss
412959 usd
us-gaap Net Income Loss
NetIncomeLoss
307536 usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12816000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12816000 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
83443 usd
CY2024Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.279 pure
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
160478 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.28 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
68849 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
120012 usd
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001138476

Files In Submission

Name View Source Status
0001185185-24-000764-index-headers.html Edgar Link pending
0001185185-24-000764-index.html Edgar Link pending
0001185185-24-000764.txt Edgar Link pending
0001185185-24-000764-xbrl.zip Edgar Link pending
ex_707398.htm Edgar Link pending
ex_707399.htm Edgar Link pending
ex_707400.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pacifichco20240630_10q.htm Edgar Link pending
pfho-20240630.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
pfho-20240630_cal.xml Edgar Link unprocessable
pfho-20240630_def.xml Edgar Link unprocessable
pfho-20240630_lab.xml Edgar Link unprocessable
pfho-20240630_pre.xml Edgar Link unprocessable
pacifichco20240630_10q_htm.xml Edgar Link completed